NEXUS
Live / Allowed — Notice of allowance issued (as of 09 Sept 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Feb 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 97778407
- Mark type
- Stylized text
- Filed
- 02 Feb 2023
- Published for opposition
- 15 Jul 2025
- Attorney of record
- Amy Rollins
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of therapeutics, namely, restoring the immune tolerance for patients with autoimmune disease
Owner
- Landos Biopharma, Inc., Roanoke, VA, US
- Landos Biopharma, Inc., Roanoke, VA, US
Prosecution history
- 09 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Jul 2025 — PUBLISHED FOR OPPOSITION
- 09 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Jan 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 03 Jan 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 03 Jan 2024 — LETTER OF SUSPENSION E-MAILED
- 03 Jan 2024 — SUSPENSION LETTER WRITTEN
- 02 Jan 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Jan 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Jan 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Nov 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Nov 2023 — NON-FINAL ACTION E-MAILED
- 06 Nov 2023 — NON-FINAL ACTION WRITTEN